{"DataElement":{"publicId":"2663833","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Pathology M Stage","preferredDefinition":"the post-neoadjuvant therapy pathologic M stage for a breast tumor, the presence of metastasis of a malignant neoplasm of the breast based on pathologic examination of a tumor specimen using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRS_TUM_P_NEO_P_M_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2663823","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Pathology M Stage","preferredDefinition":"information related to post-neoadjuvant therapy pathologic M stage for a breast tumor, the presence of metastasis of a malignant neoplasm of the breast based on pathologic examination of a sample of the tumor using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRST_TUM_P_NEOAD_P_M","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2663821","version":"1","preferredName":"Post Neoadjuvant Therapy Pathology M Stage","preferredDefinition":"Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process. (MSH98):One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C38008:C15665:C18189:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathology","conceptCode":"C18189","definition":"The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF1FAB-78ED-4C9E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"ONEDATA","dateModified":"2007-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF1FAB-78FE-4C9E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2663826","version":"1","preferredName":"Breast Tumor Post Neoadjuvant M Stage","preferredDefinition":"the post-neoadjuvant M (metastasis) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BRS_TUM_P_NEO_M_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"yM0","valueDescription":"No distant metastases","ValueMeaning":{"publicId":"2559521","version":"1","preferredName":"No distant metastases","longName":"2559521","preferredDefinition":"No clinical or radiographic evidence of distant metastases","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B58E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF3915-3346-5158-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yM1","valueDescription":"Distant Metastasis","ValueMeaning":{"publicId":"2558673","version":"1","preferredName":"Distant Metastasis","longName":"2558673","preferredDefinition":"Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Distant Metastasis","conceptCode":"C18206","definition":"A biological process that involves the transfer and growth of cancer cells from the site of the primary tumor. Relocation of malignant cells during metastasis can be restricted to movement within a specific tissue/organ or may entail migration to a distal locus within the body. This phenotype is a characteristic of all malignant tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B23E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF3915-3352-5158-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yMX","valueDescription":"Distant metastasis cannot be assessed","ValueMeaning":{"publicId":"2558675","version":"1","preferredName":"Distant metastasis cannot be assessed","longName":"2558675","preferredDefinition":"DISTANT METASTASIS CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B240-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-01-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF3915-335E-5158-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF3910-5F48-5142-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"REEVESD","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2956164","version":"1","longName":"Transcend","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2956165","version":"1","longName":"Transcend CDEs","context":"NCIP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Pathologic M Stage","type":"Preferred Question Text","description":"Pathologic M Stage","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"34FF63BD-39B6-5616-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"COOPERM","dateModified":"2012-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}